Human Mycoses: Drugs and Targets for Emerging Pathogens
- 15 April 1994
- journal article
- review article
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 264 (5157) , 371-373
- https://doi.org/10.1126/science.8153622
Abstract
No abstract availableThis publication has 34 references indexed in Scilit:
- Antimitotic agents: Chemistry and recognition of tubulin moleculeMedicinal Research Reviews, 1993
- Pneumocystis carinii pneumoniaThe Pediatric Infectious Disease Journal, 1991
- Candida albicansand three otherCandidaspecies contain an elongation factor structurally and functionally analogous to elongation factor 3FEMS Microbiology Letters, 1991
- The mechanism of antifungal action of (S)-2-amino-4-oxo-5-hydroxypentanoic acid, RI-331: The inhibition of homoserine dehydrogenase in Saccharomyces cerevisiaeBiochemical and Biophysical Research Communications, 1990
- Amphotericin B: 30 Years of Clinical ExperienceClinical Infectious Diseases, 1990
- Treatment of Experimental Invasive Aspergillosis with Novel Amphotericin B/Cholesterol-Sulfate ComplexesThe Journal of Infectious Diseases, 1989
- Biochemical basis for the interactions of type I and type II topoisomerases with DNAPharmacology & Therapeutics, 1989
- Synthesis and Evaluation of LY121019, a Member of a Series of Semisynthetic Analogues of the Antifungal Lipopeptide Echinocandin BaAnnals of the New York Academy of Sciences, 1988
- Mechanism of Action and Biochemical Selectivity of Allylamine Antimycotic AgentsAnnals of the New York Academy of Sciences, 1988
- Inhibition of sterol Δ8 → Δ7-isomerase and Δ14-reductase by fenpropimorph tridemorph and fenpropidin in cell-free enzyme systems from Saccharomyces cerevisiaePhytochemistry, 1987